Galante, E;
Okamura, T;
Sander, K;
Kikuchi, T;
Okada, M;
Zhang, MR;
Robson, M;
... Arstad, E; + view all
(2014)
Development of purine-derived (18)F-labeled pro-drug tracers for imaging of MRP1 activity with PET.
J Med Chem
, 57
(3)
pp. 1023-1032.
10.1021/jm401764a.
![[thumbnail of jm401764a.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) Preview |
PDF
jm401764a.pdf Download (1MB) |
Abstract
Multidrug resistance-associated protein 1 (MRP1) is a drug efflux transporter that has been implicated in the pathology of several neurological diseases, and is associated with development of multidrug resistance. To enable measurement of MRP1 function in the living brain, a series of 6-halopurines decorated with fluorinated side chains have been synthesized and evaluated as putative pro-drug tracers. The tracers were designed to undergo conjugation with glutathione within the brain, and hence form the corresponding MRP1 substrate tracers in situ. 6-Bromo-7-(2-[(18)F]fluoroethyl)purine showed good brain uptake and rapid metabolic conversion. Dynamic PET imaging demonstrated a marked difference in brain clearance rates between wild-type and mrp1 knockout mice, suggesting that the tracer can allow non-invasive assessment of MRP1 activity in vivo.
Archive Staff Only
 |
View Item |
